| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane neurotransmitter receptor levels | 1.32e-04 | 164 | 33 | 4 | GO:0099072 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 1.52e-04 | 65 | 33 | 3 | GO:0098815 | |
| GeneOntologyBiologicalProcess | dendrite development | 1.79e-04 | 335 | 33 | 5 | GO:0016358 | |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor diffusion trapping | 1.91e-04 | 13 | 33 | 2 | GO:0098970 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor diffusion trapping | 1.91e-04 | 13 | 33 | 2 | GO:0099628 | |
| GeneOntologyBiologicalProcess | receptor diffusion trapping | 2.23e-04 | 14 | 33 | 2 | GO:0098953 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | 2.53e-04 | 1091 | 33 | 8 | GO:0033365 | |
| GeneOntologyBiologicalProcess | negative regulation of excitatory postsynaptic potential | 2.57e-04 | 15 | 33 | 2 | GO:0090394 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 2.71e-04 | 198 | 33 | 4 | GO:0048813 | |
| GeneOntologyCellularComponent | dendrite cytoplasm | 3.77e-05 | 39 | 35 | 3 | GO:0032839 | |
| GeneOntologyCellularComponent | membrane protein complex | 6.24e-04 | 1498 | 35 | 9 | GO:0098796 | |
| GeneOntologyCellularComponent | glycoprotein complex | 7.97e-04 | 25 | 35 | 2 | GO:0090665 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 8.21e-04 | 110 | 35 | 3 | GO:0120111 | |
| GeneOntologyCellularComponent | organelle outer membrane | 1.17e-03 | 279 | 35 | 4 | GO:0031968 | |
| GeneOntologyCellularComponent | outer membrane | 1.21e-03 | 281 | 35 | 4 | GO:0019867 | |
| GeneOntologyCellularComponent | mitochondrial matrix | 1.68e-03 | 523 | 35 | 5 | GO:0005759 | |
| Domain | PDZ | 1.36e-04 | 141 | 35 | 4 | PF00595 | |
| Domain | PDZ | 1.64e-04 | 148 | 35 | 4 | SM00228 | |
| Domain | - | 1.72e-04 | 150 | 35 | 4 | 2.30.42.10 | |
| Domain | PDZ | 1.77e-04 | 151 | 35 | 4 | PS50106 | |
| Domain | PDZ | 1.81e-04 | 152 | 35 | 4 | IPR001478 | |
| Domain | - | 7.59e-04 | 391 | 35 | 5 | 2.30.29.30 | |
| Domain | FERM_C | 1.08e-03 | 26 | 35 | 2 | PF09380 | |
| Domain | PH_dom-like | 1.11e-03 | 426 | 35 | 5 | IPR011993 | |
| Domain | FERM_C | 1.16e-03 | 27 | 35 | 2 | SM01196 | |
| Domain | FERM_PH-like_C | 1.16e-03 | 27 | 35 | 2 | IPR018980 | |
| Domain | CRAL_TRIO | 1.16e-03 | 27 | 35 | 2 | PS50191 | |
| Domain | CRAL-TRIO_dom | 1.25e-03 | 28 | 35 | 2 | IPR001251 | |
| Domain | Spectrin/alpha-actinin | 1.63e-03 | 32 | 35 | 2 | IPR018159 | |
| Domain | SPEC | 1.63e-03 | 32 | 35 | 2 | SM00150 | |
| Domain | FERM_N | 1.74e-03 | 33 | 35 | 2 | IPR018979 | |
| Domain | FERM_N | 1.74e-03 | 33 | 35 | 2 | PF09379 | |
| Domain | PTPc | 2.07e-03 | 36 | 35 | 2 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 2.42e-03 | 39 | 35 | 2 | PS50055 | |
| Domain | PTPase_domain | 2.67e-03 | 41 | 35 | 2 | IPR000242 | |
| Domain | Y_phosphatase | 2.67e-03 | 41 | 35 | 2 | PF00102 | |
| Domain | FERM_M | 3.35e-03 | 46 | 35 | 2 | PF00373 | |
| Domain | FERM_central | 3.80e-03 | 49 | 35 | 2 | IPR019748 | |
| Domain | FERM_domain | 3.80e-03 | 49 | 35 | 2 | IPR000299 | |
| Domain | - | 3.80e-03 | 49 | 35 | 2 | 1.20.80.10 | |
| Domain | FERM_1 | 3.95e-03 | 50 | 35 | 2 | PS00660 | |
| Domain | FERM_2 | 3.95e-03 | 50 | 35 | 2 | PS00661 | |
| Domain | Band_41_domain | 3.95e-03 | 50 | 35 | 2 | IPR019749 | |
| Domain | B41 | 3.95e-03 | 50 | 35 | 2 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 3.95e-03 | 50 | 35 | 2 | IPR014352 | |
| Domain | FERM_3 | 3.95e-03 | 50 | 35 | 2 | PS50057 | |
| Domain | PTPc_motif | 5.46e-03 | 59 | 35 | 2 | SM00404 | |
| Domain | Tyr_Pase_cat | 5.46e-03 | 59 | 35 | 2 | IPR003595 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 39269294 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 19934217 | ||
| Pubmed | Reporting phenotypes in mouse models when considering body size as a potential confounder. | 9.84e-07 | 2 | 35 | 2 | 26865945 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 26984442 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 39390438 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 19483657 | ||
| Pubmed | Interaction of α-catulin with dystrobrevin contributes to integrity of dystrophin complex in muscle. | 2.95e-06 | 3 | 35 | 2 | 22577143 | |
| Pubmed | CaMKII binding to GluN2B is critical during memory consolidation. | 2.95e-06 | 3 | 35 | 2 | 22234183 | |
| Pubmed | PTBP-dependent PSD-95 and CamKIIα alternative splicing in the lens. | 2.95e-06 | 3 | 35 | 2 | 25540577 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 11222640 | ||
| Pubmed | 4.07e-06 | 963 | 35 | 8 | 28671696 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 15312654 | ||
| Pubmed | Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. | 6.52e-06 | 36 | 35 | 3 | 26053890 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 8.84e-06 | 281 | 35 | 5 | 28706196 | |
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 18082335 | ||
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 27170659 | ||
| Pubmed | DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. | 9.82e-06 | 5 | 35 | 2 | 20141836 | |
| Pubmed | LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity. | 1.47e-05 | 6 | 35 | 2 | 24464040 | |
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 11679592 | ||
| Pubmed | 1.99e-05 | 52 | 35 | 3 | 26499835 | ||
| Pubmed | 2.06e-05 | 7 | 35 | 2 | 21115837 | ||
| Pubmed | Quantitative traits for the tail suspension test: automation, optimization, and BXD RI mapping. | 2.06e-05 | 7 | 35 | 2 | 17619104 | |
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 23260144 | ||
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 34587162 | ||
| Pubmed | NR2B tyrosine phosphorylation modulates fear learning as well as amygdaloid synaptic plasticity. | 3.53e-05 | 9 | 35 | 2 | 16710293 | |
| Pubmed | The septin CDCrel-1 is dispensable for normal development and neurotransmitter release. | 4.40e-05 | 10 | 35 | 2 | 11739749 | |
| Pubmed | 4.40e-05 | 10 | 35 | 2 | 20124353 | ||
| Pubmed | 5.38e-05 | 11 | 35 | 2 | 12531901 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 5.63e-05 | 208 | 35 | 4 | 33230847 | |
| Pubmed | 6.45e-05 | 12 | 35 | 2 | 8615909 | ||
| Pubmed | 6.45e-05 | 12 | 35 | 2 | 12815021 | ||
| Pubmed | 6.45e-05 | 12 | 35 | 2 | 8665664 | ||
| Pubmed | 7.62e-05 | 13 | 35 | 2 | 15673434 | ||
| Pubmed | 7.62e-05 | 13 | 35 | 2 | 23576434 | ||
| Pubmed | 7.83e-05 | 82 | 35 | 3 | 20833797 | ||
| Pubmed | 8.89e-05 | 14 | 35 | 2 | 10373510 | ||
| Pubmed | 8.89e-05 | 14 | 35 | 2 | 31712124 | ||
| Pubmed | 9.18e-05 | 1487 | 35 | 8 | 33957083 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 9.27e-05 | 1489 | 35 | 8 | 28611215 | |
| Pubmed | The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. | 1.02e-04 | 15 | 35 | 2 | 14622581 | |
| Pubmed | 1.02e-04 | 15 | 35 | 2 | 9481670 | ||
| Pubmed | 1.02e-04 | 15 | 35 | 2 | 23782696 | ||
| Pubmed | Transferrin Receptor Controls AMPA Receptor Trafficking Efficiency and Synaptic Plasticity. | 1.02e-04 | 15 | 35 | 2 | 26880306 | |
| Pubmed | 1.16e-04 | 251 | 35 | 4 | 27507650 | ||
| Pubmed | 1.17e-04 | 16 | 35 | 2 | 37307456 | ||
| Pubmed | 1.19e-04 | 1139 | 35 | 7 | 36417873 | ||
| Pubmed | 1.33e-04 | 17 | 35 | 2 | 26627310 | ||
| Pubmed | 1.49e-04 | 18 | 35 | 2 | 19455133 | ||
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 1.49e-04 | 18 | 35 | 2 | 18311135 | |
| Pubmed | SHARPIN negatively associates with TRAF2-mediated NFκB activation. | 1.66e-04 | 19 | 35 | 2 | 21829440 | |
| Pubmed | 1.66e-04 | 19 | 35 | 2 | 15024025 | ||
| Pubmed | 1.85e-04 | 20 | 35 | 2 | 16635246 | ||
| Pubmed | 2.46e-04 | 23 | 35 | 2 | 30992372 | ||
| Pubmed | 3.40e-04 | 27 | 35 | 2 | 18685082 | ||
| Pubmed | Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin. | 3.66e-04 | 28 | 35 | 2 | 31600191 | |
| Pubmed | 3.66e-04 | 28 | 35 | 2 | 24448406 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 3.85e-04 | 974 | 35 | 6 | 28675297 | |
| Pubmed | The insulin receptor substrate of 53 kDa (IRSp53) limits hippocampal synaptic plasticity. | 3.93e-04 | 29 | 35 | 2 | 19208628 | |
| Pubmed | 5.03e-04 | 1442 | 35 | 7 | 35575683 | ||
| Pubmed | 5.41e-04 | 34 | 35 | 2 | 28069946 | ||
| Pubmed | 5.70e-04 | 1049 | 35 | 6 | 27880917 | ||
| Pubmed | 5.73e-04 | 382 | 35 | 4 | 29222160 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | 6.26e-04 | 1496 | 35 | 7 | 32877691 | |
| Pubmed | 6.75e-04 | 708 | 35 | 5 | 39231216 | ||
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | 8.64e-04 | 1136 | 35 | 6 | 34800366 | |
| Pubmed | A gene expression resource generated by genome-wide lacZ profiling in the mouse. | 9.06e-04 | 44 | 35 | 2 | 26398943 | |
| Pubmed | 9.54e-04 | 438 | 35 | 4 | 32628020 | ||
| Interaction | TAGAP interactions | 4.56e-06 | 19 | 35 | 3 | int:TAGAP | |
| Interaction | KCNA3 interactions | 1.29e-05 | 871 | 35 | 9 | int:KCNA3 | |
| Interaction | PLEKHA2 interactions | 2.08e-05 | 94 | 35 | 4 | int:PLEKHA2 | |
| Cytoband | 2p11.2 | 1.10e-03 | 64 | 35 | 2 | 2p11.2 | |
| GeneFamily | PDZ domain containing | 6.22e-05 | 152 | 26 | 4 | 1220 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 3.00e-04 | 18 | 26 | 2 | 812 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.33e-03 | 50 | 26 | 2 | 1293 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 186 | 35 | 4 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-05 | 196 | 35 | 4 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.65e-05 | 196 | 35 | 4 | 379132e944be2b9dcdf1a787293a48313956902c | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.75e-05 | 199 | 35 | 4 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-05 | 199 | 35 | 4 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.78e-05 | 200 | 35 | 4 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.78e-05 | 200 | 35 | 4 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.78e-05 | 200 | 35 | 4 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.78e-05 | 200 | 35 | 4 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.78e-05 | 200 | 35 | 4 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.78e-05 | 200 | 35 | 4 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.20e-04 | 150 | 35 | 3 | 4f31867cb85253ff6d22f3b02ef972a42cb41123 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.51e-04 | 157 | 35 | 3 | 84f629b7f589ca8a1abc220fa740c4a6fdc1b579 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.66e-04 | 160 | 35 | 3 | bb1bb3673059768c0ea0160d29fff127f3a4ecb4 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.66e-04 | 160 | 35 | 3 | 76f49b8b4450fa8acd36326bfa36a5d1f4bd95fb | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.81e-04 | 163 | 35 | 3 | 63b0badaee3b2d827b1f4524510e3384d8f8fcde | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.81e-04 | 163 | 35 | 3 | ce07bc424ef99c547588b07f5c8b39ff0773ca9b | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-04 | 164 | 35 | 3 | b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-04 | 164 | 35 | 3 | 3aea6207a011ad55a1aeb2ed9fb54d31b23694b5 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.96e-04 | 166 | 35 | 3 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-04 | 167 | 35 | 3 | e242827999caad08b0894d88ab97bc1df41b7650 | |
| ToppCell | facs-Aorta-Heart-24m-Endothelial-endocardial_endothelial_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 168 | 35 | 3 | edbab94f14e16a1a76546a18fe777a183080d1de | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.12e-04 | 169 | 35 | 3 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-04 | 171 | 35 | 3 | 8a0c08f0aa3a80cd6346c81deb242e430ebd897b | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.40e-04 | 174 | 35 | 3 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 175 | 35 | 3 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | Hippocampus|World / BrainAtlas - Mouse McCarroll V32 | 3.51e-04 | 176 | 35 | 3 | f120a703f6d2f2d5f55eae1aea2e6382a485828f | |
| ToppCell | normal_Lung-Endothelial_cells-EPCs|normal_Lung / Location, Cell class and cell subclass | 3.51e-04 | 176 | 35 | 3 | 71d1bd425772d89d8c550b909e0ec0e36ff22a7e | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.63e-04 | 178 | 35 | 3 | 09475e522dc1b8cf9ff1c25de5d1e3082b162948 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.63e-04 | 178 | 35 | 3 | 35de8f791b0e78a6caf52ff095f05e204a59e828 | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.63e-04 | 178 | 35 | 3 | 0139b42494c1186390b12106dea7957e2b6717c2 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.63e-04 | 178 | 35 | 3 | 000d25f3f13cc76cf39c46c312c6fafc2ea4f368 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-04 | 179 | 35 | 3 | 362c003503190dc272fa89185a83a65e063d7a67 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-04 | 179 | 35 | 3 | 9ba8693fba2175bca9ff9735cc04e657abeb9084 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-04 | 179 | 35 | 3 | 7d2e6bde00a9ab4cb21bd48b140ce205e36f9d77 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-04 | 179 | 35 | 3 | e0eec8d48868c76c3e879f219357c62ceff1bc76 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-04 | 180 | 35 | 3 | ca2a35bfb67347e47f511589a3d0f763e6664634 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-04 | 180 | 35 | 3 | 4e9e8cde2919610c4ac0025b1c9819808048bc1d | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-04 | 180 | 35 | 3 | 466381bf93c3da6a2a241daadb68e9aad2964eae | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-04 | 181 | 35 | 3 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 3.87e-04 | 182 | 35 | 3 | 9adf90bb2808f234d53b89ca0ae07380478204ad | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.94e-04 | 183 | 35 | 3 | 1645d4a55cd8c22d6eb47fc5c6b1e576c454f111 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 183 | 35 | 3 | 876b4f128c2168fdae7488201ff44f19c06c8415 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 183 | 35 | 3 | b190b650e61b1b20baf5e42d04acac82d3fd1400 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.00e-04 | 184 | 35 | 3 | 34e316ad8e7b8667cd8ad61397281802a252744f | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-04 | 184 | 35 | 3 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.00e-04 | 184 | 35 | 3 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 4.00e-04 | 184 | 35 | 3 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-04 | 185 | 35 | 3 | 808d5e880069aff8866cd2c733b9fe568a37701f | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 185 | 35 | 3 | 8433a337625ff8398520e223ef92bf9bb0beb14c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 185 | 35 | 3 | 049d793d043d5d434f143025de49dd210d18756c | |
| ToppCell | AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.06e-04 | 185 | 35 | 3 | 3b3268e3f99121124e33086cac88479808d31630 | |
| ToppCell | COVID-cycling-|COVID / Condition, Cell_class and T cell subcluster | 4.06e-04 | 185 | 35 | 3 | eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.06e-04 | 185 | 35 | 3 | fa94c4a1660967f211ba095606cd0aa37d38e17a | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 185 | 35 | 3 | 63200c42565eea596f9b00728e70e544b8d50a7f | |
| ToppCell | COVID-cycling|COVID / Condition, Cell_class and T cell subcluster | 4.06e-04 | 185 | 35 | 3 | 5112f966735fa48f0606adcfd5c0212ad5d3d77a | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-04 | 185 | 35 | 3 | daea170d827226dda6750bf1838ffd82f070c4d4 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 186 | 35 | 3 | 41f1674afc17661eccaa779cdeb663db5e45685d | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 186 | 35 | 3 | aa006650cf21a2c51dfe1091681f67fdad939107 | |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.19e-04 | 187 | 35 | 3 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-04 | 187 | 35 | 3 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.19e-04 | 187 | 35 | 3 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-04 | 187 | 35 | 3 | 9225caf66e06ebe57e90d677122acb6498607f36 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-04 | 188 | 35 | 3 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.26e-04 | 188 | 35 | 3 | 5eb107122064f0a99dfd445cc87d3766f7257216 | |
| ToppCell | AT1-AT2_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 4.26e-04 | 188 | 35 | 3 | be710bc957118cf426dd71c2d57e6f1b41c9a467 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 4.26e-04 | 188 | 35 | 3 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 4.46e-04 | 191 | 35 | 3 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.46e-04 | 191 | 35 | 3 | fcdf3a747038e346a467eae8b7c293592658b53f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-04 | 192 | 35 | 3 | b18ae7337eaad1315a5b0ee81c75f7606bd3c7fe | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.53e-04 | 192 | 35 | 3 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.53e-04 | 192 | 35 | 3 | f345b269c8cf06b004bc9419462dbc69bffaab89 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-04 | 192 | 35 | 3 | cd4c9b9ab17a779c154264f7459020f51e528ba5 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.60e-04 | 193 | 35 | 3 | e1855cff9a6bcfda9188b9fdf6c9d698405da990 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.60e-04 | 193 | 35 | 3 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-04 | 193 | 35 | 3 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.60e-04 | 193 | 35 | 3 | 22684aa2a368211baba79d29379d0bc442830524 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.60e-04 | 193 | 35 | 3 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.60e-04 | 193 | 35 | 3 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | HSPCs-Mk_prog.|HSPCs / Lineage and Cell class | 4.67e-04 | 194 | 35 | 3 | 5c05d508f5c29e6efe87506bf59e3b0fe5922f65 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.67e-04 | 194 | 35 | 3 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.67e-04 | 194 | 35 | 3 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Endothelial-A-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 4.67e-04 | 194 | 35 | 3 | e656ac5539e59e321b46706cb8cc423b2c3358a0 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 4.74e-04 | 195 | 35 | 3 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | droplet-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.74e-04 | 195 | 35 | 3 | 0c15be3e7c238e329505dcbbe197a977d1019d45 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.74e-04 | 195 | 35 | 3 | 56efeb58df19f357d7d5ce87348d4f196a595421 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 4.74e-04 | 195 | 35 | 3 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | AT2_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 4.74e-04 | 195 | 35 | 3 | 0792c1e959e933b10ae987d821ff43020dfdabad | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 4.74e-04 | 195 | 35 | 3 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | droplet-Lung-18m-Endothelial-venous_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.74e-04 | 195 | 35 | 3 | 45ac0fdbeb0982d798c613a6d15715d725608aa9 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.74e-04 | 195 | 35 | 3 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | droplet-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.74e-04 | 195 | 35 | 3 | 5b1f04a745467876b09113ee17ababd3fcf9fb01 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.74e-04 | 195 | 35 | 3 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.74e-04 | 195 | 35 | 3 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 4.74e-04 | 195 | 35 | 3 | b0cea3f4e59635913d243612f2e8cf4c7b34e726 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.74e-04 | 195 | 35 | 3 | 37aa6e4123d37de4de42ca68d3020f2a7686ce02 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.74e-04 | 195 | 35 | 3 | 7cdee2ae90edf15e4cbcf70797b8caf1f037b0ef | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 4.74e-04 | 195 | 35 | 3 | 6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a | |
| ToppCell | AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 4.74e-04 | 195 | 35 | 3 | bb45a17871a8a2593bc16a95f22e3c239c49985b | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.74e-04 | 195 | 35 | 3 | b61b8c931bd0ca3678486653ae1d7e9915c696c7 | |
| Disease | eotaxin measurement | 2.46e-06 | 80 | 35 | 4 | EFO_0008122 | |
| Disease | Nasopharyngeal carcinoma | 3.11e-04 | 22 | 35 | 2 | C2931822 | |
| Disease | CCL11 measurement | 3.40e-04 | 23 | 35 | 2 | EFO_0005188 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 8.40e-04 | 36 | 35 | 2 | DOID:11723 (implicated_via_orthology) | |
| Disease | high grade glioma (is_marker_for) | 1.14e-03 | 42 | 35 | 2 | DOID:3070 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LAGLLKKDPKQRLGG | 381 | P31751 | |
| GLGLTPEQKQKKAAL | 101 | O95831 | |
| GAKKPGLVTKNGLVL | 286 | Q3SY69 | |
| LPLGLFGAKGLKKAL | 221 | Q16570 | |
| KNPKLKILLSIGGYL | 91 | Q15782 | |
| DLGKKVLNLLKGAFP | 166 | P43378 | |
| AKKKDGGAQLLFRPL | 41 | Q9NW15 | |
| GLIGLLLARGSKIKK | 121 | Q9BUR5 | |
| PLLLGKKGIEKNLGI | 291 | P40926 | |
| PLDSLLKGDLKGVKG | 126 | O43150 | |
| KGTKPIQALLAKNIG | 1001 | Q5HYC2 | |
| KGLLTPIIKDAAAKG | 371 | O00330 | |
| GQKAKCGPKLKRLSL | 1876 | O15018 | |
| KLKGAAPLKILNIGN | 2281 | Q5S007 | |
| AKKIGPLKLAALNGL | 846 | Q16825 | |
| LGPGTAKLLKFRAIK | 416 | Q8IV32 | |
| EQAKIAKLGLKLGLL | 561 | Q9UBT7 | |
| KAKTIKPGGQILALN | 816 | Q68DX3 | |
| KSKGIALLQGSLKPV | 501 | O75417 | |
| IKLIKGPKGLGFSIA | 161 | P78352 | |
| NKLLARAAPAFLKGK | 376 | Q9Y4J8 | |
| PKGLLGAQAKLERLL | 186 | P40197 | |
| AFLKKSGLPDLILGK | 41 | P42566 | |
| NKKLKKASAEGPLLG | 16 | Q9BRJ6 | |
| PLLLADKSPLGLKGK | 176 | Q00056 | |
| PKIKLIKGEAGQNLL | 321 | P0DJD0 | |
| KPGIGAVILKRAKAL | 516 | Q9Y2M0 | |
| APQKLSVGTLKKLGL | 296 | Q96CM3 | |
| QLLGDLKPGQCTKLK | 216 | O75031 | |
| LAKGNAGKVNLPKEL | 351 | Q9UM63 | |
| IPLNLSGKAKITGKA | 701 | O95602 | |
| GQLGKPLAKKIGKLT | 5491 | Q8NF91 | |
| LKPENLLLASKLKGA | 136 | Q9UQM7 | |
| ILPILKKKLAFLSGG | 6 | Q86VW0 | |
| SLLGKNRKALAKGLG | 1671 | O15417 | |
| LLLLCIQLGGGQKKK | 31 | Q13454 | |
| IELQKKPGKGLGLSI | 1726 | O75970 |